AAPL 169.89 0.5147% MSFT 399.04 -2.4495% GOOG 157.95 -1.9553% GOOGL 156.0 -1.9669% AMZN 173.67 -1.6535% NVDA 826.32 3.7087% META 441.38 -10.5613% TSLA 170.18 4.9652% TSM 136.58 2.7149% LLY 724.87 -1.0011% V 275.16 0.0509% AVGO 1294.42 2.9917% JPM 193.37 0.1502% UNH 493.86 1.3462% NVO 125.79 -0.2933% WMT 60.21 0.5679% LVMUY 167.91 -2.1618% XOM 121.35 0.2478% LVMHF 837.0 -2.6461% MA 462.11 -0.0843%

Columbia Care Inc

Healthcare US CCHWF

NoneUSD
-(-%)

Last update at 2024-01-23T20:01:36.731565Z

Day Range

--
LowHigh

52 Week Range

0.271.50
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -432.69400M -146.71400M -136.86500M -93.85400M -36.82900M
Minority interest 5.48M 3.76M -19.71300M -1.34200M 0.94M
Net income -416.00500M -143.09700M -110.77600M -102.58900M -38.79700M
Selling general administrative 617.45M 195.73M 119.28M 108.47M 50.79M
Selling and marketing expenses - - - - -
Gross profit 201.21M 194.01M 65.98M -17.37500M 17.13M
Reconciled depreciation 84.79M 53.00M 30.27M 15.19M -
Ebit - -28.36000M -75.60100M -103.90400M -33.66300M
Ebitda -416.24000M -63.69800M -43.82700M -66.63000M -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -416.24000M -38.03700M -74.09700M -136.05500M -33.66300M
Other operating expenses - - - - -
Interest expense 53.90M 30.01M 0.00000M 0.00000M 0.00000M
Tax provision -11.21300M 0.14M -3.66500M 12.87M -
Interest income - - - - -
Net interest income -53.89700M -30.01400M -13.83100M -1.69800M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.14M -16.19700M 1.50M 2.83M
Total revenue 511.58M 460.08M 179.50M 77.46M 39.33M
Total operating expenses 927.82M 498.12M 253.60M 213.51M 72.99M
Cost of revenue 310.37M 266.06M 113.53M 94.83M 22.20M
Total other income expense net -16.45400M -78.66300M -48.93700M 43.90M -3.16600M
Discontinued operations - - - - -
Net income from continuing ops -421.48100M -146.85300M -133.20000M -106.72800M -39.66000M
Net income applicable to common shares - -143.09700M -95.78700M -96.26500M -38.79700M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 994.73M 1376.51M 792.59M 402.28M 118.37M
Intangible assets 145.26M 367.79M 100.34M 15.70M 0.00000M
Earning assets - - - - -
Other current assets 0.69M 7.94M 7.88M 107.03M 0.00000M
Total liab 787.82M 825.69M 470.71M 135.34M 119.36M
Total stockholder equity 206.90M 571.39M 341.59M 268.27M -0.98970M
Deferred long term liab - - - - 0.00000M
Other current liab 31.81M 64.47M 75.13M 35.40M 0.98M
Common stock - 550.82M 533.74M 354.93M 245.66M
Capital stock 0.00000M 0.00000M 533.74M 354.93M 1.77M
Retained earnings -904.00300M -468.33500M -325.23800M -176.20200M -68.80300M
Other liab - 176.40M 14.87M 22.48M 14.93M
Good will 19.27M 184.02M 132.81M - 0.00000M
Other assets - 12.26M 42.18M 49.03M 17.78M
Cash 48.15M 82.20M 61.11M 47.46M 0.35M
Cash and equivalents - - - - -
Total current liabilities 203.12M 244.00M 148.88M 35.40M 15.31M
Current deferred revenue - - - - -
Net debt 280.87M 78.70M 23.42M - -
Short term debt - - - - 0.00000M
Short long term debt 47.31M 1.88M 8.44M - 0.00000M
Short long term debt total - - - - 0.00000M
Other stockholder equity - - 112.46M 89.55M 25.90M
Property plant equipment - 585.23M 307.56M 183.06M 39.79M
Total current assets 237.18M 226.44M 138.24M 154.49M 160.12M
Long term investments 0.78M 0.78M - - 0.00000M
Net tangible assets - 19.59M 68.72M 252.58M 186.52M
Short term investments - - - - 0.00000M
Net receivables 10.09M 19.41M 7.65M 1.09M 43.67M
Long term debt 281.70M 159.02M 76.09M - 0.00000M
Inventory 127.91M 94.57M 54.80M 94.59M 66.86M
Accounts payable 23.77M 44.01M 18.47M 20.08M 4.03M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income - - - - 0.00000M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other 399.56M 66.78M 18.52M 12.85M 118.01M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 757.55M 1150.07M 578.89M 247.79M 118.01M
Capital lease obligations 238.21M 260.42M 210.68M 83.64M 0.00000M
Long term debt total - - - - 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -75.32700M -191.35000M -26.69700M -0.44600M 3.88M
Change to liabilities - 7.95M 5.38M 3.24M -0.14200M
Total cashflows from investing activities - -191.35000M -27.32200M -90.13400M -27.87200M
Net borrowings - 71.91M 88.64M 3.91M -16.33900M
Total cash from financing activities 153.68M 202.44M 89.99M 158.86M 85.58M
Change to operating activities - 94.19M 14.09M -2.46800M -1.79000M
Net income -416.00500M -143.09700M -95.78700M -96.26500M -38.79700M
Change in cash -33.04400M 10.56M 13.02M 1.68M 32.94M
Begin period cash flow 82.53M 61.11M 47.46M 46.24M -
End period cash flow 49.49M 82.53M 61.11M 47.46M 46.24M
Total cash from operating activities -111.40100M -0.52300M -49.65000M -67.04700M -24.76600M
Issuance of capital stock 0.00000M 133.56M - 114.59M -
Depreciation 84.79M 53.00M 19.65M 8.69M 4.68M
Other cashflows from investing activities - -22.81100M 0.99M -20.34600M -10.27200M
Dividends paid - - - - -
Change to inventory -44.30100M -18.03300M -17.25800M -12.66700M -6.61000M
Change to account receivables 8.09M -6.33300M -4.57400M -0.17700M -0.83200M
Sale purchase of stock - 0.00000M 0.00000M -2.41300M -
Other cashflows from financing activities - -1.22900M 0.96M 152.22M 152.22M
Change to netincome - 1.73M 24.23M 32.63M 18.57M
Capital expenditures 72.74M 117.51M 42.88M 77.44M 14.53M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -50.54500M 81.42M -0.49000M -11.02600M -
Stock based compensation 27.93M 25.02M 28.94M 28.87M -
Other non cash items -27.67800M -50.40000M 23.74M 0.34M -
Free cash flow -184.14200M -118.02900M -85.49100M -137.18800M -

Fundamentals

  • Previous Close -
  • Market Cap521.35M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA25.84M
  • Revenue TTM512.70M
  • Revenue Per Share TTM1.28
  • Gross Profit TTM 201.68M
  • Diluted EPS TTM-0.84

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CCHWF
Columbia Care Inc
- -% - - 25.25 0.90 0.96 1.99 -62.2064
ZTS
Zoetis Inc
2.48 1.64% 153.36 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
-0.37 1.14% 32.07 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
6.97 4.40% 165.33 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR
-0.16 1.21% 13.07 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

Profile

The Cannabist Company Holdings Inc. engages in the cultivation, manufacture, and provision of cannabis products and related services in the United States and internationally. The company offers spanning flower, edibles, oils, and tablets under the Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand names. It holds licenses in 17 jurisdictions in the United States. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The company was founded in 2012 and is headquartered in New York, New York.

Columbia Care Inc

680 Fifth Avenue, New York, NY, United States, 10019

Key Executives

Name Title Year Born
Mr. Nicholas Keane Vita Co-Founder, CEO & Director 1973
Mr. David J. Hart Chief Operating Officer 1977
Mr. Derek Watson Chief Financial Officer 1971
Dr. Rosemary Mazanet M.D., Ph.D. Chief Scientific Officer 1956
Mr. Bryan Lamont Olson Chief People & Admin. Officer 1974
Ms. Lee Ann Evans VP of Investor Relations NA
Kate Driscoll VP of Compliance NA
Mr. David Sirolly Chief Legal Officer & Gen. Counsel 1975
Mr. Bryant Ison Chief Marketing Officer NA
Mr. Guy Jacques Hussussian Chief Data Officer 1967

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).